Daniel D De Carvalho Selected Research

Paclitaxel (Taxol)

1/2014

Constitutive androstane receptor ligands modulate the anti-tumor efficacy of paclitaxel in non-small cell lung cancer cells.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Daniel D De Carvalho Research Topics

Disease

34	Neoplasms (Cancer) 04/2024 - 05/2012
3	Glioma (Gliomas) 04/2024 - 01/2019
3	Prostatic Neoplasms (Prostate Cancer) 01/2022 - 01/2020
3	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 01/2022 - 01/2016
3	Breast Neoplasms (Breast Cancer) 01/2022 - 01/2020
2	Inflammation (Inflammations) 01/2023 - 01/2017
2	Leukemia 01/2022 - 01/2021
2	Triple Negative Breast Neoplasms 01/2022 - 01/2020
2	Hematologic Neoplasms (Hematological Malignancy) 01/2022 - 10/2010
2	Renal Cell Carcinoma (Grawitz Tumor) 10/2020 - 01/2020
2	Disease Progression 01/2020 - 09/2015
2	Colorectal Neoplasms (Colorectal Cancer) 01/2020 - 08/2015
2	Melanoma (Melanoma, Malignant) 12/2019 - 01/2018
2	Carcinogenesis 01/2019 - 01/2018
1	Porcine Reproductive and Respiratory Syndrome (PRRS) 05/2023
1	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 01/2023
1	Glioblastoma (Glioblastoma Multiforme) 01/2023
1	Chordoma 12/2022
1	Squamous Cell Carcinoma of Head and Neck 01/2021
1	Preleukemia 01/2021
1	Down Syndrome (Down's Syndrome) 01/2021
1	Ovarian Neoplasms (Ovarian Cancer) 01/2020
1	Ewing Sarcoma (Sarcoma, Ewing) 01/2020
1	Genomic Instability 01/2019
1	Testicular Neoplasms (Testicular Cancer) 01/2019
1	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 10/2017
1	Reinfection 10/2017
1	Infections 10/2017
1	Lung Neoplasms (Lung Cancer) 01/2014
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2014

Drug/Important Bio-Agent (IBA)

10	DNA (Deoxyribonucleic Acid)IBA 11/2021 - 05/2012
7	Retroelements (Retrotransposon)IBA 01/2024 - 01/2018
7	Cell-Free Nucleic AcidsIBA 10/2022 - 10/2017
4	Biomarkers (Surrogate Marker)IBA 09/2023 - 11/2018
4	Histones (Histone)IBA 01/2023 - 10/2010
4	ChromatinIBA 01/2023 - 01/2018
3	EnzymesIBA 04/2024 - 11/2021
3	InterferonsIBA 09/2023 - 01/2018
3	Antiviral Agents (Antivirals)IBA 01/2023 - 11/2021
2	Proteins (Proteins, Gene)FDA Link 01/2024 - 01/2020
2	DNA Transposable Elements (Element, IS)IBA 05/2023 - 01/2019
2	Transcription Factors (Transcription Factor)IBA 01/2023 - 12/2019
2	AndrogensIBA 01/2022 - 01/2020
2	Double-Stranded RNA (RNA, Double Stranded)IBA 01/2022 - 01/2018
2	CytokinesIBA 01/2021 - 01/2019
2	Circulating Tumor DNAIBA 01/2021 - 10/2017
2	Immune Checkpoint InhibitorsIBA 01/2020 - 11/2018
2	ElementsIBA 01/2018 - 01/2018
1	Isocitrate Dehydrogenase (Isocitrate Dehydrogenase (NAD+))IBA 04/2024
1	Exonucleases (3' 5' Exonuclease)IBA 01/2024
1	Pattern Recognition ReceptorsIBA 05/2023
1	Pathogen-Associated Molecular Pattern MoleculesIBA 05/2023
1	Histone Deacetylase InhibitorsIBA 01/2022
1	Androgen Antagonists (Antiandrogens)IBA 01/2022
1	Androgen Receptor AntagonistsIBA 01/2022
1	PanobinostatIBA 01/2022
1	Interferon Type IIBA 01/2022
1	RNA (Ribonucleic Acid)IBA 11/2021
1	Nucleic AcidsIBA 11/2021
1	Carrier Proteins (Binding Protein)IBA 01/2021
1	CohesinsIBA 01/2021
1	MicroRNAs (MicroRNA)IBA 01/2021
1	durvalumabIBA 01/2020
1	Membrane Proteins (Integral Membrane Proteins)IBA 01/2020
1	PlatinumIBA 01/2020
1	Estrogen ReceptorsIBA 01/2020
1	taxaneIBA 01/2020
1	TESIBA 01/2020
1	cc-486IBA 01/2020
1	Small Interfering RNA (siRNA)IBA 12/2019
1	ChemokinesIBA 01/2019
1	AntigensIBA 01/2019
1	Tumor Suppressor Proteins (Proteins, Tumor Suppressor)IBA 01/2018
1	RNA-Induced Silencing ComplexIBA 01/2018
1	Histone DemethylasesIBA 01/2018
1	Protein-Tyrosine Kinases (Tyrosine Kinase)IBA 10/2017
1	Peptidoglycan (Murein)IBA 10/2017
1	Interleukin-10 (Interleukin 10)IBA 10/2017
1	AcetyltransferasesIBA 10/2017
1	Intergenic DNA (Junk DNA)IBA 09/2017
1	Anti-Bacterial Agents (Antibiotics)IBA 01/2017
1	isocitric acid (isocitrate)IBA 01/2016
1	Interleukin-6 (Interleukin 6)IBA 09/2015
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 09/2015
1	Antineoplastic Agents (Antineoplastics)IBA 01/2014
1	Constitutive Androstane ReceptorIBA 01/2014
1	Paclitaxel (Taxol)FDA LinkGeneric 01/2014
1	LigandsIBA 01/2014
1	MethyltransferasesIBA 05/2012

Therapy/Procedure

14	Therapeutics 01/2024 - 09/2017
6	Immunotherapy 11/2021 - 03/2016
2	Castration 01/2021 - 01/2020
1	Heterologous Transplantation (Xenotransplantation) 01/2021
1	Lasers (Laser) 01/2020
1	Drug Therapy (Chemotherapy) 01/2020